采用BCG的INTERLEUQIN-15超激动剂 - - 是一个重大的治疗进步还是朝着正确的方向迈出的一小步?
Eugene J Pietzak1, Harry W Herr1
1Urologic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York.
NEJM evidence
|February 6, 2024
概括
肠道Bacillus Calmette-Guérin (BCG) 对于非肌肉侵入性膀癌 (NMIBC) 有效,但复发很常见. 新的标准有助于识别不对BCG反应的患者,指导膀癌的治疗.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 在过去的40多年里,肠道Bacillus Calmette-Guérin (BCG) 已经成为非肌肉侵入性膀癌 (NMIBC) 的标准治疗方法.
- 尽管它是有效的,但瘤复发和进展的高率被观察到,特别是在本位癌症 (CIS) 患者中.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
